Acetylspiramycin

乙酰螺旋霉素

Report date: 2026/03/04 20:01:44

Base Information

Drug NameAcetylspiramycin
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics
Mechanisms of Action50S ribosomal subunit inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryJapan
Original Approved Date1967/09/01
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesAspen PharmaSinopharm Wuhan Zhonglian Siyao Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ01FA02
Related LinksKEGG